BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1814 related articles for article (PubMed ID: 27497913)

  • 1. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Premotor diagnosis of Parkinson's disease].
    Morales-Briceño H; Cervantes-Arriaga A; Rodríguez-Violante M
    Gac Med Mex; 2011; 147(1):22-32. PubMed ID: 21412393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease: a short story of 200 years.
    Cuenca L; Gil-Martinez AL; Cano-Fernandez L; Sanchez-Rodrigo C; Estrada C; Fernandez-Villalba E; Herrero MT
    Histol Histopathol; 2019 Jun; 34(6):573-591. PubMed ID: 30540129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease.
    Béné R; Antić S; Budisić M; Lisak M; Trkanjec Z; Demarin V; Podobnik-Sarkanji S
    Acta Clin Croat; 2009 Sep; 48(3):377-80. PubMed ID: 20055267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF, Mechanism of Action, Role in Parkinson's Disease, and Therapeutics.
    Liu Y; Deng J; Liu Y; Li W; Nie X
    Front Pharmacol; 2021; 12():675725. PubMed ID: 34234672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Role of Caffeine in the Treatment of Parkinson's Disease.
    Roshan MH; Tambo A; Pace NP
    Open Neurol J; 2016; 10():42-58. PubMed ID: 27563362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Parkinson's disease: a review of SNCA and LRRK2.
    Konno T; Siuda J; Wszolek ZK
    Wiad Lek; 2016; 69(3 Pt 1):328-32. PubMed ID: 27486710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story.
    Vermeiren Y; De Deyn PP
    Neurochem Int; 2017 Jan; 102():22-32. PubMed ID: 27899296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
    Brain Struct Funct; 2014 Sep; 219(5):1513-26. PubMed ID: 24135772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobehavioral Analysis to Assess Olfactory and Motor Dysfunction in Parkinson's Disease.
    Panda SR; Panja P; Soni U; Naidu VGM
    Methods Mol Biol; 2024; 2761():511-528. PubMed ID: 38427259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease.
    Pradhan S; Andreasson K
    Exp Neurol; 2013 Mar; 241():148-55. PubMed ID: 23261765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the pathology of Parkinson's disease.
    Jellinger KA
    J Neural Transm Suppl; 2002; (62):347-76. PubMed ID: 12456078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
    Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
    Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia and Parkinson's disease: footprints to pathology.
    Lazdon E; Stolero N; Frenkel D
    J Neural Transm (Vienna); 2020 Feb; 127(2):149-158. PubMed ID: 32016606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.
    Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.